Dr. Anthony Fauci, a leading voice for understanding HIV and infectious diseases in the U.S. government for a quarter century, often draws a crowd when he speaks—because of his ability to concisely say what needs to be done. Today, he did just that. Speaking at a briefing on global HIV-TB issues sponsored by the Center […]
Welcome to our live blog just across from the U.S. Capitol, where more than 100 HIV and TB scientists, policymakers, and advocates have come together for a symposium titled “Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis.” Two back-to-back sessions—sponsored by the Center for Global Health Policy and the Global Health Council—will feature […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Jacqueline Hellen and Lisa Parker of MEASURE Evaluation While programs in low- and middle-income countries seek to support children […]